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1. Introduction 
 
1.1. Equine Grass Sickness 
 
Equine grass sickness (EGS), or equine dysautonomia, is a polyneuropathy affecting 
the central, peripheral and enteric nervous systems of grazing horses.1 
Although EGS has been recognized for nearly 100 years the cause has not been 
definitively determined.2 Recent studies showed that intoxication with Clostridium 
botulinum type C is involved in EGS3, but it is very likely that EGS has a multifactorial 
aetiology. 
 
1.1.1. Symptoms 
 
There are two distinct clinical presentations of EGS. The first form, acute grass 
sickness, presents as colic, with rapid development of clinical signs. This form is 
invariably fatal and all cases die or require euthanasia, usually within 7 days. 
Symptoms of acute grass sickness are dysphagia, hyper salivation (see Fig. 1), 
complete anorexia, nasogastric reflux and absence of gut sounds. Other clinical 
signs not attributed to the gastrointestinal tract are depression, dehydration, 
tachycardia and muscle tremors.4 
                                            
1
 McGorum et al. (2000) 
2
 Wylie et al. (2009) 
3
 Cottrell et al (1999) 
4
 Wylie et al. (2009) 
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Fig. 1: A horse showing marked hypersalivation (common cases of acute grass sickness).5 
 
The second clinical presentation of EGS is chronic grass sickness, which is mainly 
characterized by weight loss or dysphagia. Other clinical signs associated with failure 
of normal gastrointestinal function are mild colic, inappetence and severe weight loss 
(development of a “wasp-waist”, see Fig. 2). Systemic clinical signs not attributable to 
gastrointestinal tract dysfunction are sweating, depression, rhinitis sicca and 
behavioral changes like “playing with drinking water”. Survival of this form may be 
possible. It is unusual for EGS to recur in recovered individuals, although there are 
sporadic unconfirmed reports.6  
 
                                            
5
 Wylie et al. (2009) 
6
 Wylie et al. (2009) 
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Fig. 2: The typical clinical presentation of a chronic grass sickness case displaying marked 
weight loss and the appearance of a ‘‘wasp-waist.’’7 
 
 
1.1.2. Geographic distribution 
 
EGS occurs most frequently in Great Britain, where the first outbreak was recognized 
in eastern Scotland in 1909. Epidemiologic studies have suggested there are 
identifiable high-risk areas throughout the United Kingdom with a high proportion of 
cases occurring in Scotland, but with cases also occurring in England and Wales. 
EGS is considered to occur rarely in Ireland, with only three reported cases. EGS has 
also been reported in many countries in Western Europe, including France, 
Germany, Hungary, Norway, Sweden, Austria, Switzerland, the Netherlands, 
Belgium, Denmark, Finland, Cyprus and Luxembourg. 
The prevalence is considered to be highest in countries geographically close to Great 
Britain, in particular Germany and Belgium.8 
                                            
7
 Wylie et al. (2009) 
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1.1.3. Risk factors 
 
The currently favored theory is that EGS is a form of toxico-infectious botulism, 
resulting from Clostridium botulinum producing toxins locally within the horse’s 
intestinal tract.9 According to Hunter et al., C. botulinum Type C was shown present 
in 48% of ileum samples from horses with EGS compared to 7% with control samples 
from healthy horses. Since C. botulinum type C toxin in gastrointestinal contents can 
also be found in with healthy horses10 it is likely that other factors are involved in the 
aetiology of EGS. 
The following clinical signs are common to both botulism and EGS: anorexia, colic, 
dysphagia, hypersalivation, tachycardia and weight loss. Mydriasis, profound 
myasthenia and respiratory distress are features unique to botulism.  
As the name suggests, there is a strong association between the development of 
EGS and access to grazing. There are only rare isolated reports of cases in horses 
without access to fresh grass.11 Although cases may occur in any month, peaks in 
the diagnoses occur during the spring and early summer.12 Young horses and those 
who have recently moved premises are at significantly increased risk.13 Animals in 
contact with previous cases are at a 10-fold lower risk.14 
Results of epidemiological studies also showed that premises on loam and sand soils 
had increased rates of recurrence, whereas premises on chalk and other soil types 
                                                                                                                                        
8
 Wylie et al. (2009) 
9
 Newton et al. (2004) 
10
 Hunter et al. (1999) 
11
 Wylie et al. (2009) 
12
 Newton et al. (2004) 
13
 McCarthy et al. (2001) 
14
 Newton et al. (2004) 
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had significantly reduced rates of recurrence. Soil inhabitants such as earthworms 
and moles, are able to burrow more freely though sand and loam soil types, causing 
disruption and increasing the rate of soil contamination. Therefore it is more likely for 
C. botulinum to reside in these soil types and hence bringing the bacterium into 
contact with grazing horses more frequently. 
 
1.1.4. EGS and Ranunculus 
 
The aim of this research was to find out if Ranunculus samples from EGS sites are 
significantly different compared to Ranunculus samples from sites, where EGS has 
not occurred.  Our hypothesis is that Ranunculus might be another factor involved in 
the aetiology of equine grass sickness. The following facts support this hypothesis: 
• Fresh Ranunculus contains Ranunculin, a glycoside that is enzymatically 
hydrolyzed to produce Protoanemonin, a toxic metabolite that can cause 
blistering and gastrointestinal irritation. Therefore buttercups might be able to 
evoke lesions in the gastrointestinal tracts of the horses. This may allow the 
bacterium Clostridium botulinum to enter the bloodstream.  
• EGS occurs only in horses with access to fresh grass. Ranunculus contains 
the irritant metabolite Protoanemonin that dimerizes into the non-toxic 
Anemonin when the plant is dried. Therefore intoxication is only possible if 
horses ingest fresh Ranunculus. 
• EGS occurs more often in young horses. In general, grazing animals reject 
Ranunculus because of its acrid taste, but when other food is scarce or when 
young animals are first turned out to pasture they tend to overeat them. Under 
these conditions some animals may develop a taste for the plants and 
6 
continue to eat them, even deliberately choosing them when other food is 
available.15 
• Ingestion of Ranunculus by horses can cause excitation, muscle tremor, 
paralysis, conjunctivitis, ablepsia, deafness and colic.16 Some of these 
symptoms are also typical for EGS.  
•  The peak of EGS outbreak is in spring. During this time Protoanemonin levels 
in the plants are usually elevated. 
 
In order to test this hypothesis Ranunculus samples were collected at 12 sites where 
EGS has occurred as well as 9 control sites where EGS has not occurred. Another 
aim of these studies was to find out if there are seasonal changes in the metabolite 
profiles. Therefore 10 samples have been collected at one site, but at different times 
of the year.  
 
1.2. Ranunculus - species 
 
1.2.1. Ranunculus repens 
 
R. repens is also called creeping buttercup. The plant reaches heights from 10 to 50 
cm and has a creeping rhizome. The leaves are three-lobed and they grow out of the 
nodes. The sepals are close to the petals and the pedicles are sulcate.17 
                                            
15
 Cooper, Johnson (1988) 
16
 Habermehl, Ziemer (1999) 
17
 Lauber et al. (2007) 
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1.2.2. Ranunculus acris 
 
Other common names for R. acris are common buttercup; field buttercup, tall 
buttercup and crowfoot. R. acris is a 30 to 80 cm high, perennial herb with a short 
rhizome.18The stems are erect or may creep along the ground but do not form roots. 
The basal leaves have long stalks and the upper ones short stalks. The leaf blades 
are hairy and deeply divided into 2-7 lobes which are deeply indented and toothed.19 
 
1.2.3. Ranunculus bulbosus 
 
R. bulbosus is also called St. Anthony’s turnip. It is a perennial, hairy plant that grows 
from a rounded or flattened stem tuber which bears fleshy roots. The stems are 
usually erect up to 40 cm high and bear deeply cut, three-lobed leaves of which the 
central lobe is long-stalked.20 Unlike R. acris and R. repens, R. bulbosus has a bulb-
like swollen corm. R. bulbosus has been used as a homoeopathic drug. Its 
indications go from menstrual pain to coronary diseases and rheumatism.21 
 
1.2.4. Ranunculus sceleratus 
 
Other common names for R. sceleratus are celery-leaved buttercup and cursed 
crowfoot. This plant is generally an annual although it occasionally survives a winter. 
                                            
18
 Frohne, Pfänder (1997) 
19
 Cooper,Johnson (1988) 
20
 Cooper, Johnson (1988) 
21
 Habermehl, Ziemer (1999) 
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The plant has fibrous roots and a stout, erect, hollow stem which grows up to 60 cm 
high. The lower leaves have long stalks with three deeply segmented, toothed lobes 
near the top, giving them a superficial resemblance to edible celery, although the 
stalks are thinner. The stem-leaves have short stalks and are divided into narrower 
segments. This is reputed to be the most poisonous Ranunculus species.22  
 
1.3. Ranunculus – compounds and pharmacological effects 
 
Ranunculus contains the lactones Protoanemonin, Ranunculin and Anemonin. These 
ingredients also occur in Anemone, Pulsatilla, Clematis and Helleborus.23 
Intoxications in humans are rather rare, but the handling of fresh cut plants may 
cause contact dermatitis. This local irritation has been used in former times for the 
removal of warts.24 
 
1.3.1. Ranunculin 
 
Formula 1: Ranunculin 
Ranunculin is a glycoside that enzymatically hydrolyses into glucose and its toxic 
metabolite Protoanemonin. This hydrolysis can also occur when leaves are dried, 
crushed or bruised or by alkaline hydrolysis and steam distillation. 25  
                                            
22
 Cooper, Johnson (1988) 
23
 Frohne, Pfänder (1997) 
24
 Habermehl, Ziemer (1999) 
25
 Martz (2008) 
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1.3.2. Protoanemonin 
 
Formula 2: Protoanemonin 
 
Protoanemonin is a volatile, oily, irritant substance. Protoanemonin has high affinity 
for SH groups. Its toxic effect as a sub-epidermal vesicant is possibly caused by 
inactivation of enzymes containing SH groups.26 
The clinical signs of Protoanemonin poisoning are similar in all animal species. In 
early stages, salivation, inflammation of the mouth and abdominal pain occur. They 
may be followed by severe ulcerations of the mouth and damage to the digestive and 
urinary systems. Colored diarrhea and dark or blood stained urine are produced and 
at this stage the animals have an unsteady gait, particularly of the hind legs; vision is 
often impaired or lost. Convulsions usually precede death, although fatal poisoning is 
rare.27 In contact with the skin, it produces sub-epidermal disjunction and bulla 
formation by disruption of sulphur bridges.28 
Protoanemonin is not stable and dimerizes into Anemonin when the plant is dried. 
Therefore it is harmless to feed hay containing Ranunculus.29 Protoanemonin has 
also been shown to possess fungicidal30,31, antimicrobial32 and antimutagenic33 
properties.  
                                            
26
 Frohne, Pfänder (1997) 
27
 Cooper, Johnson (1988)  
28
 Karaca et al. (2005) 
29
 Habermehl, Ziemer (1999) 
30
 Misra, Dixit (1980) 
31
 Martín et al. (1990) 
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1.3.3. Anemonin 
 
Formula 3: Anemonin 
 
Anemonin has shown fungicidal (but it is not as potent as its precursor 
Protoanemonin)34 and antispasmodic35 properties. Anemonin is able to modulate the 
expression of iNOS and therefore inhibit NO production. This could be responsible 
for its anti-inflammatory effects.36 Furthermore it inhibits melanin synthesis in human 
melanocytes37. Both Anemonin and Protoanemonin participate in the sedating 
effect.38 
 
                                                                                                                                        
32
 Tocan, Baron (1969) 
33
 Minakata et al. (1983) 
34
 Misra, Dixit (1980) 
35
 Roth et al. (2006)  
36
 Lee et al. (2008) 
37
 Huang et al. (2008) 
38
 Martin et al. (1988) 
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1.4. 1H-NMR metabolomics 
 
High resolution 1H-NMR spectroscopy with chemometric analysis offers an innovative 
way to assess whole plant extracts. The potential of metabolomics is currently 
explored in a wide range of fields including as an efficient method for quality control 
of phytomedicines. It also provides an important tool for the identification of 
chemotypes and targets bioactive compounds.39  
All the chemical components present in a plant extract are viewed simultaneously as 
a “metabolic fingerprint” in an 1H-NMR spectrum. Such data can be analyzed using 
different chemometric methods, since the spectra are far too complex to be 
interpreted visually.40 The complex “metabolic fingerprint” generated can 
subsequently be visualised by application of multivariate statistical data analysis in 
order to reduce the complexity of the data and to detect the pattern of changes 
relating to environmentally or genetically induced variations in metabolite 
composition.41  
Statistical methods which can be used include principal component analysis (PCA) 
and partial least squares (PLS).   
 
                                            
39
 Cardoso-Taketa et al. (2008) 
40
 Rasmussen et al. (2006) 
41
 Wang et al. (2004) 
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1.4.1. Nuclear magnetic resonance (NMR) 
 
Some nuclei carry a total spin (1H, 2H, 13C, 15N...) resulting in a magnetic moment. 
Only these nuclei can be detected by NMR42. In NMR-spectroscopy samples of liquid 
or solid material are exposed to an external static and homogenous magnetic field B0 
The magnetic moments due to spin-1/2 particles can only align parallel or anti-
parallel with respect to the external field. For the detection of the NMR signal, a high-
frequency magnetic field B1 is applied orthogonal to the external magnetic field for a 
defined time period. This is called a B1-pulse. Afterwards the magnetization starts to 
precess around B0.43 The nuclei release this energy in the form of cosinusoidal 
oscillation, called the ‘free induction decay’. Via a mathematical operation called 
Fourier-transformation this signal can be transformed into the NMR-spectrum44. 
The resonances are influenced in characteristic ways by the environments of the 
observed nuclei. In molecules, nuclei are always surrounded by electrons and other 
atoms. The result of this is that the effective magnetic field Beff at the nucleus is 
always less than the applied field B0. The effect, although small, is measurable. It is 
usually expressed as the σ-value or chemical shift. Before each measurement a 
reference compound is added to the sample:  it is therefore called internal standard. 
Usually tetramethylsilan (TMS) is used for this purpose. It contains 12 highly shielded 
protons, which means only a small amount needs to be added, and it is chemically 
inert and it gives only one sharp peak45.  
 
                                            
42
 Herzog, Messerschmidt (1995) 
43
 Lindon et al. (2007) 
44
 Herzog, Messerschmidt (1995) 
45
 Friebolin (2005) 
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1.4.2. Principal Component Analysis (PCA) 
 
Principal Component Analysis (PCA) condenses the multivariate data into a reduced 
number of principal components that describe the greatest amount of variance in the 
data. Each PC (principal component) is a linear combination of the original variables 
whereby each successive PC explains the maximum amount of variance possible in 
the dataset and each PC is orthogonal to every other PC.  
By applying such a technique to the NMR data, similarities and differences between 
samples can be visualised in simple two- or three-dimensional scores plots.46 By 
visual analysis of the scores plots groupings, trends and outliers can be found. 
Objects or samples that are close to each other in the scores plot have a similar 
multivariate profile. Conversely, objects that lie far from each other have dissimilar 
properties.  
The loadings plot describes the influence of variables and the relation among them. 
An important feature is that directions in the score plot correspond to directions in the 
loading plot, and vice versa.47  
For example samples with negative scores are associated with negative peaks in the 
loadings plot. 
 
 
 
                                            
46
 Wang et al. (2004) 
47
 Lindon et al. (2007) 
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1.4.3. Regression 
 
Partial least squares (PLS) is a method for relating two data tables. The Y data table 
can be both quantitative (e.g. metal levels, number of EGS cases) and qualitative 
(e.g. control/EGS samples) data.48 Interpretation of the relationship between X-data 
and Y-data is then simplified as this relationship is concentrated on the smallest 
possible number of components. By looking at the first PLS components it is possible 
to view main associations between X-variables and Y-variables, and also 
interrelationships within X-data and within Y-data. 
In these studies PLS was used to prove if there is a relation between the variation 
within the metabolic profiles of the samples (X-data) and the number of EGS cases 
that occurred at each site (Y-data).  
                                            
48
 Lindon et al. (2007) 
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2. Materials and methods 
 
2.1. Materials 
 
2.1.1. Plant material 
 
The plants were collected and frozen afterwards by Dr. Sarah Edwards and Prof. Dr. 
Michael Heinrich, Centre for Pharmacognosy and Phytotherapy, between April 2007 
and March 2009. The samples of plant material can be divided into three groups: 
• Control samples from Golder Manor Farm, that were collected at different times 
of the year (G) 
• Control samples from various sites where no cases of Equine Grass Sickness 
had been reported (C) 
• Samples from sites where Equine Grass Sickness cases had occurred (E) 
The plant material that was used for the development of the method was collected at 
Golder Manor Farm, Oxfordshire, by Dr. Sarah Edwards, Centre of Pharmacognosy 
and Phytotherapy, between May and August 2008. 
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Table 1: Golder Manor Farm sample data 
 
Name of the 
sample Species 
Date of 
collection Site 
G1 R. repens 12.11.2007 Golder Manor Farm 
Oxfordshire 
G2 R. repens 5.5.2008 Golder Manor Farm 
Oxfordshire 
G3 R. repens 23.5.2008 Golder Manor Farm 
Oxfordshire 
G4 R. repens 5.6.2008 Golder Manor Farm 
Oxfordshire 
G5 R. repens 8.7.2008 Golder Manor Farm 
Oxfordshire 
G6 R. repens 22.8.2008 Golder Manor Farm 
Oxfordshire 
G7 R. repens 28.1.2009 Golder Manor Farm 
Oxfordshire 
G8 R. repens 20.2.2009 Golder Manor Farm 
Oxfordshire 
G9 R. repens 6.3.2009 Golder Manor Farm 
Oxfordshire 
G10 R. repens 12.3.2009 Golder Manor Farm 
Oxfordshire 
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Table 2: Control sample data 
 
Number of 
the sample Species 
Date of 
collection Site 
C1 R. acris 28.11.2007 London Equestrian Centre 
London 
C7 R. repens 11.6.2008 Swarebrook Great Milton 
Oxfordshire 
C8 R. acris 11.6.2008 Swarebrook Great Milton 
Oxfordshire 
C9 R. repens 8.7.2008 Overstone Grange 
Northamptonshire 
C10 R. repens 15.7.2008 East Bog Farm 
Angus 
C11 R. repens 23.7.2008 Checkendon Equestrian Centre 
Berkshire 
C12 R. acris 23.7.2008 Checkendon Equestrian Centre 
Berkshire 
C13 R. acris 23.7.2008 Wyfold RDA 
Oxfordshire 
C14 R. repens 28.7.2008 Town Farm 
Buckinghamshire 
C15 R. repens 28.7.2008 Great House Farm 
Hertfordshire 
C16 R. acris 28.7.2008 Town Farm 
Buckinghamshire 
C17 R. repens 29.8.2008 Potter’s Field 
Buckinghamshire 
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Table 3: Equine Grass Sickness sample data 
 
Sample 
number Species 
Number 
of cases 
Date of 
last case 
Date of 
collection Site 
E1 R. acris 1 4.4.2007 15.5.2007 Culbeg Farm 
Stirlingshire 
E2 R. acris 1 4.4.2007 15.5.2007 Culbeg Farm 
Stirlingshire 
E3 R. repens 2 11.5.2005 17.5.2007 Burgie House 
Morayshire 
E5 R. repens 5 19.5.2007 25.5.2007 Home Farm 
Northamptonshire 
E6 R. repens 5 19.5.2007 25.5.2007 Home Farm 
Northamptonshire 
E7 R. acris/  
R. repens 
4 22.5.2007 5.6.2007 Bransby Rest Home 
Lincolnshire 
E8 R. repens 1 23.4.2007 12.6.2007 Middle of the World Farm 
Hampshire 
E9 R. acris 4 9.7.2007 30.7.2007 Catlip’s Farm 
Hertfordshire 
E10 R. repens 4 13.8.2007 20.8.2007 Poplar’s Riding Centre 
Buckinghamshire 
E11 R. bulbosus 4 13. 8. 2007 20.8.2007 Poplar’s Riding Centre 
Buckinghamshire 
E12 R. repens 2 2.12.2007 13.12.2007 Light Ash Farm 
Lancashire 
E13 R. repens 2 10.12.2007 29.1.2008 Hendaffrn 
Powys 
E14 R. bulbosus 2 8.5.2008 15.5.2008 Willow Lodge 
Hertfordshire 
E15 R. bulbosus 2 8.5.2008 15.5.2008 Willow Lodge 
Hertfordshire 
E16 R. repens 2 8.5.2008 15.5.2008 Willow Lodge 
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Hertfordshire 
E17 R. repens 1 6.5.2008 19.5.2008 Wargrave Manor 
Berkshire 
E18 R. repens 1 6.5.2008 19.5.2008 Wargrave Manor 
Berkshire 
E19 R. repens 1 17.7.2008 28.7.2008 Hillcrest Farm 
Suffolk 
 
2.1.2. Analytical apparatus 
 
1H-NMR experiments (400 MHz) were conducted on a Bruker Avance instrument.  
The NMR data was processed using Topspin software. Amix viewer was used to 
transform the NMR spectra into a data table. The data was normalized in Excel. PCA 
and PLS were performed using Unscrambler. 
 
2.1.3. Chemicals 
 
Methanol, hexane, ethyl acetate and chloroform (all HPLC grade) were obtained from 
Fisher Scientific, UK. Deionised water was produced with an Elix from Millipore, 
France. Deuterated chloroform (99.8%) and deuterated Methanol (99.8%) were 
obtained from Cambridge Isotope Laboratories, Inc., Cambridge, UK. Deuterium 
oxide (99.9%) was obtained from GOSS Scientific Instruments Ltd., Cambridge, UK. 
3-(Trimethylsilyl) propionic-2,2,3,3-d4 acid ,sodium salt (98%) and tetramethylsilane 
(99.9%) were obtained from Sigma-Aldrich, Germany.  
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2.2. Methods 
 
2.2.1. Extraction of the plant material 
 
In order to obtain a broad range of differing polarity compounds and a high 
Ranunculin yield a method similar to the one developed by Bai et al.49 was used.  
All samples were extracted using the same extraction method. All samples were 
extracted in a triplicate.  
 The frozen plant material (aerial parts) was lyophilized for about 24 hours and was 
afterwards ground in a mortar. The powder was put into a beaker for three hours to 
soak with methanol, and then put into a column (diameter 1.5 cm) and covered with 
methanol over night. The following day, the plant material was extracted with 
methanol for six hours. The extract was dried under reduced pressure, then 
transferred into a vial and dried under nitrogen. The dried extract was stored in a 
freezer until further sample preparation. 
Sample data that was collected during the extraction process can be found in the 
appendix. 
                                            
49
 Bai et al.(1996) 
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2.2.2. Fractionation of the extracts 
 
2.2.2.1. Reasons for fractionating the extracts 
 
Crude methanol extracts consist of hundreds of metabolites within a wide range of 
polarities and have only low contents of Ranunculin and its metabolites. Due to this it 
is difficult to interpret their NMR spectra (see Fig. 3) and PCA results. In order to 
obtain extracts with a higher concentration of toxic metabolites the crude methanol 
extracts were partitioned between solvents with different polarities. The obtained 
fractions were analysed using 1H-NMR. The 1H-NMR spectra of each fraction was 
examined for the existence of toxic lactones such as Ranuculin, Ranunculin-aglycon, 
Protoanemonin or Anemonin by comparing them with spectral data of the pure 
compounds.  
 
Fig. 3: 1H-NMR of a crude methanol extract in MeOD 
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2.2.2.2. NMR data of Ranunculin and its metabolites 
 
Table 4: 1H-NMR data of Ranunculin in MeOD50 
 
 
 
 
 
 
Position δH multiplicity J 
2 6.19 dd 2.2 Hz 
5.6 Hz 
3 7.74 dd 1.4 Hz 
6.0 Hz 
4 5.33 m  
5 4.11 
3.88 
m 
m 
 
1’ 4.32 dd 7.6 Hz 
2’ 3.17 m  
3’ 3.35 dd 1.6 Hz 
4’ 3.27 dd 0.8 Hz 
5.2 Hz 
5’ 3.66 
 
m  
6’ 3.84 
3.31 
m 
m 
 
 
Table 5: 1H-NMR data of the aglycon in CDCl3
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 Position δH multiplicity J 
 
2 6.22 dd 2.1 Hz 
5.8 Hz 
3 7.48 dd 1.5 Hz 
5.8 Hz 
4 5.16 m  
5a 4.00 dd 3.4 Hz 
12.1 Hz 
5b 3.80 dd 5.1 Hz 
   12.1 Hz 
 
 
                                            
50
 Martz (2008)  
51
 Bai et al. (1996) 
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Table 6: 1H-NMR data of the Protoanemonin in CDCl3
52
 
 
 Position δH multiplicity J 
 
 
2 6.38 dd 5.6 Hz 
0.7 Hz 
3 7.72 dd 1.9 Hz 
5.6 Hz 
5a 5.08 dd 2.8 Hz 
0.7 Hz 
5b 5.28 dd 2.8 Hz 
   1.9 Hz 
 
Table 7: 1H-NMR data of the Anemonin in MeOD53 
 
 Position δH multiplicity J 
 
 
2 
2’ 
6.18 d 5.3 Hz 
3 
3’ 
8.08 d 5.3 Hz 
5a 
5a’ 
2.61 m  
5b 
5b’ 
5.35 m  
    
 
 
                                            
52
 Blasco et al. (1995) 
53
 Huang et al. (2008) 
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2.2.2.3. Experiments to fractionate the extracts 
 
• Method 1 
 
Fig. 4: Schematic diagram of method 1 
 
The dried methanol extract was partitioned in a separating funnel between 20 ml of 
water and 20 ml of chloroform three times. The chloroform layers (extract 1) were 
dried under reduced pressure and with nitrogen. Afterwards the chloroform extract 
was lyophilized, dissolved in CDCl3 (10 mg/ml) and analysed with 
1H-NMR (Fig. 5). 
 
Fig. 5: 1H-NMR of an example of extract 1 (chloroform) in CDCl3 
 
The water layer (extract 2) was freeze-dried and dissolved in D2O. Due to the 
formation of precipitate it was not possible to analyse the water extract with 1H-NMR.  
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• Method 2 
 
 
Fig. 6: Schematic diagram of method 2 
 
The dried methanol extract was dissolved in 20ml of 85% methanol and transferred 
into a separating funnel. The extract was partitioned with 20ml of hexane three times. 
The hexane layers (extract 3) were dried under reduced pressure and with nitrogen, 
and were then lyophilized. The dried hexane extract was dissolved in CDCl3 
(10mg/ml) and analysed with 1H-NMR (Fig. 7). 
 
Fig. 7: 1H-NMR of an example of extract 3 (hexane) in CDCl3 
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The 85% methanol layer was partitioned with 20 ml of ethyl acetate. No separation of 
layers could be obtained, so an extra 10 ml of water were added to the separation 
funnel. The ethyl acetate phase (extract 4) was dried under reduced pressure, with 
nitrogen and was then lyophilized. The dried ethyl acetate extract was dissolved in 
CDCl3 (10mg/ml) and analysed with 
1H-NMR (Fig. 8) 
 
Fig. 8: 1H-NMR of an example of extract 4 (ethyl acetate) in CDCl3 
 
The 1H-NMR spectra of the ethyl acetate fraction showed resonance peaks 
corresponding to those of the Ranunculin aglycon (for spectral data, see Table 5).   
The methanol-water layer (extract 5) was dried under reduced pressure, with 
nitrogen and was then lyophilized. The dried extract was dissolved in MeOD 
(10mg/ml) but couldn’t be analysed because it formed precipitate.  
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• Method 3 
 
Fig. 9: Schematic diagram of method 3 
 
The dried methanol extract was dissolved in 100 ml of 90% methanol and partitioned 
with 100ml of hexane three times. The hexane layers (extract 6) were dried under 
reduced pressure, with nitrogen and were then lyophilized. The hexane extract was 
dissolved in CDCl3 (10mg/ml) and analysed with 
1H-NMR (Fig. 10). 
 
Fig. 10: 1H-NMR of an example of extract 6 (hexane) in CDCl3 
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40ml of water were added to the methanol layer. The now 70% methanol layer was 
partitioned with 100 ml chloroform three times. The chloroform layers (extract 7) were 
dried under reduced pressure, with nitrogen and were then lyophilized. The dried 
chloroform extract was dissolved in CDCl3 (10mg/ml) and analysed with 
1H-NMR 
(Fig. 11). 
 
Fig. 11: 1H-NMR of an example of extract 7 (chloroform) in CDCl3 
 
The 1H-NMR spectra of the chloroform fraction showed resonance peaks 
corresponding to those of the Ranunculin aglycon (for spectral data, see Table 5).  
The 70% methanol layer was partitioned with butanol three times (1:1). The butanol 
layers (extract 8) were dried under reduced pressure, with nitrogen and were then 
lyophilized. The dried butanol extract was dissolved in of CDCl3 (10mg/ml) and 
analysed with 1H-NMR (Fig. 12). 
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Fig. 12: 1H-NMR of an example of extract 8 (butanol) in MeOD 
 
The remaining water layer (extract 9) was freeze-dried, dissolved in D2O (10mg/ml) 
and analysed with 1H-NMR (Fig. 13). 
 
Fig. 13: 1H-NMR of an example of extract 9 (water) in D2O 
 
• Conclusions 
 
Method 3 was the most suitable method because it was possible to analyse all 
fractions with 1H-NMR. The chloroform fraction had the highest concentration of 
Ranunculin-aglycon. The NMR spectra of all other fractions did not show resonance 
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peaks for Ranunculin or any of its metabolites. Because it is possible that not only 
the concentration of toxins, but the whole range of metabolites in the extract might be 
involved in EGS, both the crude methanol extracts, as well as their chloroform 
fractions were analysed. 
 
2.2.3. Sample preparation 
 
• The dried crude methanol extract was dissolved in 50 ml methanol.  
• 5 ml of the solution (10% of the total methanol extract) were dried with 
nitrogen and then lyophilized (methanol extract). 
• In order to increase the solvent’s polarity 5ml of water were added to the 
remaining 45 ml of the solution. 50 ml of a solution of the extract in 90% 
methanol were obtained.  
• The extract was partitioned with 50 ml of hexane in order to separate apolar 
compounds (e.g. chlorophyll) from the extract. The hexane extract was then 
discarded. 
• 15 ml of water were added to the 90% methanol fraction in order to increase 
its polarity. 65 ml of 70% methanol were obtained. 
• The 70% methanol fraction was partitioned with 50 ml of chloroform 3 times. 
• The chloroform fractions were collected in a round bottom flask and dried 
under reduced pressure and nitrogen, and the extract was lyophilized 
(chloroform extract). 
 
31 
2.2.4. NMR analysis 
 
The methanol extracts were dissolved in deuterated methanol (MeOD) containing 
0.01% TSP to a concentration of 10 mg/ml. The chloroform extracts were dissolved 
in deuterated chloroform (CDCl3) containing 0.01% TMS to a concentration of 10 
mg/ml. The solutions were transferred into 5mm NMR tubes. 1H-NMR spectra were 
recorded on a Bruker Avance 400 spectrometer. For each sample 128 transients 
were collected. The spectra were referenced to the internal TMS or TSP.  
1H-NMR spectra were corrected for phase and baseline distortions using Topspin. 
 
2.2.5. Data reduction and statistical analysis 
 
Before analysis by multivariate methods the spectra were reduced in complexity by 
using the “bucketing” function to generate a number of integrated regions of the data 
set. The spectra in the range of σ0.2 – σ10.5 ppm were divided into 257 regions 
(“buckets”) of 0.04 ppm using AMIX software and the signal intensity in each region 
was integrated. Water signals (σ4.6 – σ5.0 ppm in MeOD spectra), residual proton 
signals corresponding to MeOD (σ3.24 – σ3.4 ppm) and CDCl3 (σ7.2 – σ7.4 ppm) 
and internal standard peaks (σ-0.2 – σ0.2 ppm) were removed. This data table could 
then be imported into Microsoft Excel for the addition of labels and normalization. 
The spectral areas were normalized to the total sum of the spectra integral. PCA and 
PLS were carried out on the normalized NMR dataset using mean- centered scaling 
with the software Unscrambler. The results were validated with full cross validation. 
PCA and PLS summarized the variance in the spectra into 5 principal components.  
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3. Results 
 
3.1. PCA (Principal Component Analysis) 
3.1.1. Comparison of different species 
 
PCA was carried out for methanol extracts on the complete data set (samples from 
Golder Manor farm (G), samples from other control sites (C) and EGS sites (E)). A 
five component model explained 86% of the variance, with the first two components 
explaining 67%. Fig. 14 shows the PCA scores plot (PC1/PC2) for all methanol 
extracts. A strong classification between two groups of samples is evident in the 
second principal component (the PC2 direction). 
 
Fig. 14: Scores plot (PC1 (50%) vs. PC2 (17%)) of different methanol extracts 
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This differentiation is caused by the fact that there are three different Ranunculus 
species: R. repens, R. acris and R. bulbosus. With the exception of some outliers 
(C1, C7, E1, E2 and E17), R. acris and R. bulbosus samples grouped together, 
indicating that the chemical composition of these two species is similar (Fig. 15 and 
Fig. 16).  
 
 
Fig. 15: Scores plot (PC1 (50%) vs. PC2 (17%)) of all methanol extracts. R. repens (R), R. 
acris (A), R. bulbosus (B). 
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Fig. 16: Scores plot 
(PC2 (17%)) of all 
methanol extracts. R. 
repens (blue), R. acris 
(red), R. bulbosus 
(green). 
 
Fig. 17: Loadings plot 
(PC2 (17%)) of all 
methanol extracts 
 
 
Since R. acris and R. bulbosus can be found in the lower half of the scores plot, the 
negative loadings are associated with R. acris and R. bulbosus. Examination of the 
loadings plot of PC2 (Fig. 17) showed that negative loadings appear mainly in the 
carbohydrate region (σ4.4 – σ2.3 ppm). On the other hand the positive loadings, 
which are associated with R. repens, appear in the aromatic region (σ8.0 – σ5.5. 
ppm). There are no visible loadings for Ranunculin aglycon (1H-NMR data in CDCl3: 
7.48 (H-3), 6.22 (H-2), 5.16 (H-4), 4.00 (H-5a), 3.80 (H-5b) ppm), therefore 
Ranunculin aglycon concentration is not one of the main differences between the 
metabolic profiles of different Ranunculus species.   
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The same experiment was carried out on all chloroform extracts. 86% of the total 
information could be explained by a five component model, with the first two 
components explaining 57%. Sample E10 had to be taken out of the analysis, 
because it was very different to all other samples. 
The scores plot of PC1/PC2 showed no clear differentiation between the different 
species (Fig. 18).  
 
 
Fig. 18: Scores plot (PC1 (32%) vs. PC2 (25%)) of all chloroform extracts 
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The loadings plot of PC2 (Fig. 20) showed positive loadings corresponding to the 
resonance peaks of the Ranunculin aglycon. This showed that the concentration of 
Ranunculin aglycon is an important characteristic for the differentiation of the 
chloroform extracts. Therefore it can be estimated that samples with positive PC2 
scores (located in the upper half of the scores plot) have higher contents of 
Ranunculin aglycon. The scores plot of PC2 showed high scores for all R. acris 
samples (C12, C13, C16, E1, E2, E7 and E9), with the exception of sample C1. This 
indicates that R. acris has higher toxin content than R. repens or R. bulbosus. 
Although most R. repens samples have lower PC2 scores, there are also some 
samples with very high PC2 scores (E3, E5, E7, E8, E19, C9, G2). 
 
 
Fig. 19: Scores plot (PC2 
(25%)) of all chloroform 
extracts. R. repens (blue), 
R. acris (red), R. bulbosus 
(green). 
 
 
Fig. 20: Loadings plot (PC2 
(25%)) of all chloroform 
extracts. Resonance peaks 
of Ranunculin aglycon (red). 
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3.1.2. Comparison of R. acris and R. bulbosus 
 
Although R. acris and R. bulbosus appear to have a very similar chemical 
composition it was possible to detect a difference comparing only extracts of these 
two species. 
Fig. 21 shows the PCA scores plot for methanol extracts of R. acris (C1, C8, C12, 
C13, C16, E1, E2, E7 and E9) and R. bulbosus (E11, E14 and E15). A differentiation 
is evident in the first principal component (PC1). All R. bulbosus samples (with the 
exception of E15/3) group together as a cluster. Sample E9 (R. acris) has similar 
properties as R. bulbosus samples.  
 
 
Fig. 21: Scores plot (PC1 (56%) vs. PC2 (21%)) of methanol extracts of R. acris (A) and R. 
bulbosus (B). 
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Fig. 22: Scores plot (PC1 
(56%)) for methanol 
extracts of R. acris (red) 
and R. bulbosus (green). 
 
 
Fig. 23: PCA loadings plot 
(PC1 (56%)) for methanol 
extracts of R. acris (red) 
and R. bulbosus (green). 
 
 
The loadings plot of PC1 (Fig. 23) shows clearly that the differentiation of the clusters 
results from differences in the resonance regions of σ2.5 – σ4.5 ppm and σ0.5 – σ2.5 
ppm. Generally negative loadings, which are associated with R. acris show high 
peaks in the carbohydrate region, whereas positive loadings (associated with R. 
bulbosus) appear mainly in the aliphatic region.  
 
3.1.3. Comparison of different seasons 
 
In order to detect changes relating to environmentally or genetically induced 
variations in the metabolite composition it was necessary to compare R. repens 
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samples only. Without the variation between different species it was possible to find 
out if the season of sample collection has an impact on the plant’s chemical 
composition. Samples G1, G7, G8, G9, G10, E12 and E13 were collected in winter 
(between November and March). Samples G2, G3, E3, E5, E6, E16, E17 and E18 
were collected in spring (May) and G4, G5, G6, C7, C9, C10, C11, C14, C15, C17, 
E8, E10 and E19 were collected in summer (between June and August).  
The PCA scores plot for methanol extracts (Fig. 24) showed no clustering in the first 
two principal components, but the scores plot of PC3/PC4 showed a cluster of 
samples that were collected in winter (with the exception of E12/2 and E13/3). There 
was no apparent differentiation between samples collected in spring and in summer. 
This indicates that there are only minor differences between the metabolite 
composition of plants during their vegetation period and in winter. 
 
Fig. 24: Scores plot (PC3 (8%)/PC4 (6%)) of R. repens methanol extracts. Spring (SP), 
summer (S), winter (W). 
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The loadings plot of PC4 (Fig. 26) showed that negative loadings, which are 
associated with samples collected in winter appear mainly in the aliphatic region 
(σ2.30 – σ0.00 ppm), whereas positive loadings correspond to peaks in the 
carbohydrate and aromatic region (σ9.00 – σ2.30 ppm). 
 
 
 
Fig. 25: Scores plot (PC4 
(6%)) of R. repens methanol 
extracts. Spring (SP), 
summer (S), winter (W). 
 
Fig. 26: Loadings plot (PC4 
(6%)) of R. repens methanol 
extracts.  
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PCA was also carried out with all chloroform extracts of R. repens samples. 
The scores plot of PC2/PC3 showed that samples in winter are predominantly 
located in the right half of the scores plot (Fig. 27). However there are many samples 
collected in summer and spring with similar properties, so this differentiation is not 
very specific. 
 
 
Fig. 27: Scores plot (PC1 (37%) vs. PC2 (25%)) of R. repens chloroform extracts. Spring 
(SP), summer (S), winter (W). 
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By comparing the PC2 scores plot with its loadings plot (Fig. 28 and Fig. 29), it was 
possible to show that most samples collected in winter have lower contents of 
Ranunculin aglycon. On the other hand, most samples collected in spring have 
negative PC2 scores and therefore high Ranunculin aglycon concentration.  
 
 
Fig. 28: Scores plot (PC2 
(25%)) of R. repens 
chloroform extracts. Spring 
(SP), summer (S), winter 
(W). 
 
Fig. 29: Loadings plot (PC2 
(25%)) of R. repens 
chloroform extracts. 
Ranunculin aglycon (red). 
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3.1.4. Samples from only one site 
 
Comparing samples from only one site (Golder Manor Farm) that have been 
collected at different times of the year, makes it easier to draw conclusions about 
seasonal differences. In this experiment the impact of environmental factors (such as 
geological properties or different climates) has been minimized.   
Samples collected in winter form a cluster in PC2/PC3. The loadings plot of PC3 
showed positive loadings between σ3.2 - σ4.2 ppm and σ 5.2 – σ5.6 ppm which 
correspond to samples collected in winter. The results showed that samples collected 
in winter differ from samples collected in spring or summer.  
 
Fig. 30: Scores plot (PC2 (27%) vs. PC3 (10%)) of methanol extracts from Golder Manor 
Farm. Spring (SP), summer (S), winter (W). 
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Fig. 31: Loadings plot (PC3 
(10%)) of methanol extracts 
from Golder Manor Farm.  
 
 
PCA was also carried out on all chloroform extracts from Golder Manor farm. 
Samples collected in winter were predominantly located in the right half of the scores 
plot of PC1/PC2 (Fig. 32).  
 
 
Fig. 32: PCA scores plot (PC1 (45%) vs. PC2 (29%)) of chloroform extracts from Golder 
Manor Farm. Spring (SP), summer (S), winter (W). 
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3.1.5. Comparison of EGS and control sites 
 
To evaluate the main purpose of these studies, whether samples from EGS sites are 
significantly different from samples from control sites, it is important to compare only 
samples from one species. Therefore PCA was carried out on only R. repens 
methanol extracts from all Equine Grass sickness sites and control sites. 
The scores plot of PC1/ PC 2 showed a cluster of control samples (with the exception 
of C7) whereas there was a higher variation between the EGS samples (Fig. 33, Fig. 
34 and Fig. 35). 
 
 
Fig. 33: Scores plot (PC1 (62%) vs. PC2 (14%)) of methanol extracts from control (C) and 
EGS sites (E).  
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Fig. 34: Scores plot (PC1 (62%)) 
of methanol extracts from control 
(C) and EGS sites (E). 
 
 
Fig. 35: Scores plot (PC2 (14%)) 
of methanol extracts from control 
(C) and EGS sites (E). 
 
The same experiment was carried out on the chloroform extracts. Even though the 
clustering of control samples is not as evident as for the methanol extracts the overall 
picture is very similar (Fig. 36). The loadings plot for PC2 (Fig. 37) showed positive 
loadings corresponding to the resonance peaks of the Ranunculin aglycon. Therefore 
samples with positive PC2 scores (located in the upper half of the scores plot) have 
higher contents of Ranunculin aglycon. Most control samples (with the exception of 
C7 and C9) have low PC2 scores, so their Ranunculin aglycon concentrations are 
approximately lower. 
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Fig. 36: Scores plot (PC1 (40% vs. PC2 (21%)) of chloroform extracts from control (C) and 
EGS sites (E). 
 
 
Fig. 37: Loadings plot (PC2 (21%)) of chloroform extracts. Resonance peaks for Ranunculin 
aglycon (red) 
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3.2. PLS-DA (partial least squares - discriminant analysis) 
 
PLS-DA was carried out on methanol extracts of R. repens samples from Equine 
Grass Sickness (E) and control sites (C). The y variable was defined as either 0 (no 
EGS case occurred) or 1 (EGS cases had occurred). A five component model 
explained 87% of the variance within the x variables (spectra), with the first two 
components explaining 74%.  45% of this variation could be explained by the y 
variable (0 or 1).  
The scores plot of PC1/2 (Fig. 38) showed a cluster of all control sites with the 
exception of C7.  
 
 
Fig. 38: PLS-DA scores plot (PC1 (48%) vs. PC2 (26%) of methanol extracts from Equine 
Grass Sickness (E) and control (C) samples. 
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PLS-DA was also carried out on chloroform extracts of R. repens samples from 
Equine Grass Sickness (E) and control sites (C). A five component model explained 
83% of the variance within the x variables (spectra), with the first two components 
explaining 32%. 53% of this variation could be explained by the y variable (0 or 1).  
The scores plot of PC1/2 (Fig. 38) showed a cluster of all control sites with the 
exception of C7 and C17. 
 
 
Fig. 39: PLS-DA scores plot (PC1 (17%) vs. PC2 (15%) of chloroform extracts from Equine 
Grass Sickness (E) and control (C) samples. 
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The loadings plot for PC1 (Fig. 41) showed positive loadings corresponding to the 
resonance peaks of the Ranunculin aglycon. Therefore samples with negative PC1 
scores (Fig. 40) have lower contents of Ranunculin aglycon. Most control samples 
(with the exception of C7) have low PC1 scores, so their Ranunculin aglycon 
concentrations are approximately lower. 
 
 
Fig. 40: PLS-DA scores plot 
(PC1 (17%)) of chloroform 
extracts from Equine Grass 
Sickness (red) and control  
samples (green) 
 
 
Fig. 41: PLS-DA loadings 
plot (PC1 (17%)) of 
chloroform extracts. 
Resonance peaks for 
Ranunculin aglycon (red). 
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3.3. PLS (partial least squares) 
 
3.3.1. Number of EGS cases 
 
The previous experiment was repeated with the y variable defined as the number of 
EGS cases that occurred at each site (see Table 3: Equine Grass Sickness sample 
data). A five component model explained 87% of the variance within the x variables 
(spectra), with the first two components explaining 58%. 41% of this variation could 
be explained by the y variable (number of EGS cases). The scores plot of PC1/2 
showed a cluster of control sites, with the exception of sample C7. This result is 
similar to the results of PCA and PLS-DA analysis, but the classification is even more 
evident.  
 
Fig. 42: PLS scores plot (PC1 (13%) vs. PC2 (45%)) of methanol extracts from Equine Grass 
Sickness (E) and control (C) samples. 
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The same experiment was carried out on the chloroform extracts. A five component 
model explained 84% of the variance within the x variables (spectra), with the first 
two components explaining 50%. 62% of this variation could be explained by the y 
variables (number of EGS cases). The scores plot shows clustering of control 
samples (with the exception of C7) mainly in the left lower half of the plot. 
 
 
Fig. 43: PLS scores plot (PC1 (26% vs. PC2 (24%)) of chloroform extracts from Equine 
Grass Sickness (E) and control (C) samples. 
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The loadings plot for PC1 (Fig. 45) showed positive loadings corresponding to the 
resonance peaks of the Ranunculin aglycon. Therefore samples with negative PC1 
scores (Fig. 44) have lower contents of Ranunculin aglycon. Most control samples 
(with the exception of C17) have low PC1 scores, so their Ranunculin aglycon 
concentrations are lower. 
On the other hand there are also some EGS samples (E16, E17and E18) with low 
PC1 scores.  
 
 
Fig. 44: PLS scores plot (PC1 
(26%)) of chloroform extracts 
from Equine Grass Sickness 
(red) and control samples 
(green). 
 
 
Fig. 45: PLS loadings plot 
(PC1 (26%)) of chloroform 
extracts. Resonance peaks 
for Ranunculin aglycon (red). 
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3.3.2. Soil analysis 
 
For this experiment the y variable was defined as the level of properties of soil 
samples that had been collected at the same sites by Dr. Sarah Edwards (see Table 
8 and Table 9 in the appendix). Nitrate levels are elevated in most samples from 
EGS sites. The more of the variation in the spectra can be explained by the variation 
in the soil property levels, the higher the possibility that there might be a relation. As 
can be seen in Fig. 46, a high percentage of the variation in the methanol extracts 
can be explained by the levels of ammonium nitrogen, available iron and fluoride.  
 
 
Fig. 46: Explained variances of X variables (spectra) and Y variables (soil properties) in % for 
the methanol extracts. 
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Fig. 47 showed that there might be a relationship between levels of nitrate nitrogen 
and total iron, chromium, fluoride, aluminium and the metabolic profiles of the 
chloroform extracts.  
 
 
Fig. 47: Explained variances of X variables (spectra) and Y variables (soil properties) in % for 
the chloroform extracts. 
 
All PLS scores plots (PC1/PC2) are displayed in the appendix (see page V). 
The scores plots of nitrate nitrogen, cadmium and chromium show clustering 
between EGS and control samples of the methanol extracts, which might be a sign 
that these metals are involved in the aetiology of EGS. Looking at the chloroform 
extracts, there is clustering in the scores plot of available iron. 
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4. Discussion 
 
4.1. Comparison of EGS and control samples 
 
The aim of this study was to establish whether there is a significant difference 
between Ranunculus samples from EGS sites compared to those from control sites. 
 
The results of the metabolomic analysis show that control samples (with exception of 
sample C7) group together and therefore have similar properties (see Fig. 33, Fig. 38 
and Fig. 42). On the other hand, there is a lot of variation between the metabolic 
profiles of samples from EGS sites.  
This might be a sign that there are environmental factors at EGS sites that increase 
metabolic stress for the plants that grow on these premises. This observation has 
also been made by McGorum et al.54, who observed weak prooxidant activity of plant 
extracts collected at EGS pastures.  
By means of partial least squares the variation in the extracts was correlated with the 
number of EGS cases that occurred at each site (Fig. 42). In the PLS analysis the 
grouping between control samples became even more evident. The EGS samples 
can approximately be divided into two groups that lie within close distance in the PLS 
scores. The first group consists of the samples E3, E5, E6, E7, E12 and E13, and the 
second group of samples E16, E17, E18, E19 and C7, which is an outlier of the 
control group.  
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A possible reason for this differentiation is that samples of the first group have been 
collected in 2007 (except E13, which has been collected in January 2008), and 
samples of the second group have been collected in 2008.  
The time of freezing might have an impact on the metabolite composition of the plant 
material. Bai et al.55 showed that Ranunculin hydrolyzes completely when stored in 
the freezer for 6 months. However, it is unclear how the time of freezing affects the 
entire metabolic profile.  
Another possible explanation is that the climatic conditions during these two years 
were very different.  
 
By observing scores plots (Fig. 36, Fig. 40 and Fig. 44) of the chloroform extracts it 
was possible to estimate that the majority of samples collected at equine grass 
sickness sites (E1, E2, E3, E5, E6, E7, E8, E10, E11, E12, and E18) contain 
elevated levels of Ranunculin aglycon. Even though there are also control samples 
with elevated Ranunculin aglycon levels (G2, C12, C13 and C14, see Fig. 16) these 
results support the hypothesis that Ranunculus is involved in the aetiology of Equine 
Grass Sickness. 
The results suggest that not only high Ranunculin content but the whole range of 
plant metabolites might be involved in the aetiology of EGS (Fig. 33, Fig. 38 and Fig. 
42). Nevertheless interpretation of these results is complicated, because both 
environmental as well as genetic factors have an impact on metabolic profiles of 
plants. 
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4.2. Comparison of different species 
 
Metabolomics proved to be a powerful tool for showing the differences in the 
metabolite composition of the three species R. repens, R. acris and R. bulbosus (Fig. 
15, Fig. 16 and Fig. 17). All R. acris samples, with the exception of sample C1, have 
high Ranunculin aglycon concentrations. Most R. repens samples have lower PC2 
scores, indicating they have a lower Ranunculin content, but there are also some 
with high PC2 scores (E3, E4, E5, E7, E8, E19, C9 and G2). 
Looking at the whole metabolic profile, it is not possible to define certain metabolites 
as being typical for a certain Ranunculus species (Fig. 17). However, it can be said 
that the variation in Ranunculin aglycon concentration is not one of the main 
differences between the metabolic profiles of different Ranunculus species. 
Furthermore the results clearly showed that the chemical composition of R. acris and 
R. bulbosus are more similar compared to R. repens.  
 
4.3. Comparison of different seasons 
 
EGS cases occur mainly in spring or summer. Therefore most samples from EGS 
sites have been collected between May and August. Only samples E12 (December) 
and E13 (January) have been collected in winter. Control samples were collected at 
all times of the year to find out if there are seasonal changes in the metabolic profile. 
The results show that samples collect in winter differ from samples collected in spring 
or summer (Fig. 24and Fig. 30). However these are only minor differences, since 
they can only be observed in higher principal components. Therefore the impact of 
the season of collection is smaller than expected.  
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Furthermore, the results showed that the concentrations of Ranunculin aglycon are 
generally lower in winter, and elevated in spring (Fig. 28 and Fig. 29).  
Since EGS outbreaks most likely occur in spring, the fact that toxin levels are 
elevated in spring supports the hypothesis that Ranunculus is involved in EGS. 
 
4.4. Limitations 
 
4.4.1. Geographical location 
 
The metabolomics results show that all control sites (with the exception of C7) group 
together in one cluster (Fig. 33, Fig. 38 andFig. 42). One possible explanation for this 
could be that all control samples (with the exception of sample C10 from Angus and 
C9 from Northamptonshire) have been collected within close geographical distance. 
Some of the EGS samples were collected in different parts of Great Britain and within 
greater geographical distance. Therefore it is likely that there is more variation 
between their metabolic profiles. 
 
4.4.2. Composition of the plant material 
 
The metabolic profile is also dependent on the composition of the plant material. 
Most of the samples had no or hardly any flowers, with the exception of sample E19, 
which consisted almost only of flowers. The results of the metabolic analysis show 
sample E19 as an outlier (Fig. 14, Fig. 33 and Fig. 36). The theory that Ranunculin is 
more concentrated in the reproductive organs, such as flowers, cannot be supported 
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because the 1H-NMR spectra showed that E19 had very low levels of Ranunculin 
aglycon. 
Furthermore it should make a difference if the plant material contains a majority of 
stems or leaves. Variations in the composition of the plant material should be 
avoided, but plant material is always inhomogenous.  
In order to minimize these variations and to ensure the reproducibility of the method, 
all samples have been extracted three times. Even though the extraction procedure 
was the same for all samples, the metabolomics results show differences for some 
samples within these repeats. With the exception of E3, E6, E18 and G8, the method 
showed good reproducibility for the three repeats (Fig. 14). 
 
4.4.3. Time of freezing 
 
Ranunculin and Protoanemonin are unstable compounds. The longer the samples 
are frozen the higher the levels of Ranunculin aglycon will be56. Samples that have 
been collected a long time ago (E1, E2, E3 and E5) have high concentrations of 
Ranunculin aglycon (Fig. 19). 
 
4.4.4. Amount of Ranunculus 
 
Although these results support the hypothesis that Ranunculus could be involved in 
the aetiology of equine grass sickness there are certain factors that cannot be 
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included in a phytochemical analysis. First, the amount of Ranunculus that grows at 
the pastures. There might be premises on which Ranunculus with a high 
concentration of toxins is growing, but the prevalence for these plants is very low.  
On the other hand, there could be cases at farms where Ranunculus has very low 
levels of toxins, but the plants grow more frequently, so that a horse eats larger 
amounts of Ranunculus. Furthermore we do not know the amount of Ranunculus the 
horse actually eats. As mentioned before, horses generally avoid eating Ranunculus, 
but if other food is rare or if they develop a taste for it, it is possible.  
 
4.5. Conclusion 
 
The results of these studies support the hypothesis that Ranunculus is involved in the 
aetiology of Equine Grass Sickness. 
By using principal component analysis it was possible to show a clear differentiation 
between samples from EGS sites and samples from control sites. Regression 
analysis results indicated that there is a relation between the variation of the 
chemical composition of the plants and the number of EGS cases that occurred at 
each farm.  
Since the chemical composition of plants is dependent on various factors, like 
climatic condition and geographical location, interpretation of these results is very 
complicated. 
 Consequently, the results of this analysis cannot be seen as a definite proof that 
there is a relationship between Ranunculus and Equine Grass Sickness. For drawing 
final conclusions on this matter, further studies, phytochemical as well as 
pharmacological, are required. 
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5. Abstract 
 
Equine grass sickness (EGS), or equine dysautonomia, is a polyneuropathy affecting 
the central, peripheral and enteric nervous systems of grazing horses. EGS occurs 
most frequently within Great Britain, although it is also recognized in regions of 
mainland Europe. It affects predominantly young horses with access to pasture in 
springtime. Although EGS has been recognized for nearly 100 years the cause has 
not been definitively determined. Recent studies showed that intoxication with 
Clostridium botulinum type C is involved in EGS, but it is very likely that EGS has a 
multifactorial aetiology. 
The aim of this study was find out if there is a relation between phytochemical data of 
Ranunculus samples and EGS. To test this hypothesis a phytochemical analysis was 
carried out on Ranunculus samples from 12 sites where there have been EGS 
outbreaks as well as samples from 9 control sites where EGS has not occurred. 
Fresh Ranunculus contains Ranunculin, a glycoside that is enzymatically hydrolyzed 
to produce Protoanemonin, a toxic metabolite that can cause blistering and 
gastrointestinal irritation. Therefore buttercups might be able to evoke lesions in the 
gastrointestinal tracts of the horses. This may allow the bacterium Clostridium 
botulinum to enter the bloodstream.  
For the phytochemical analysis all Ranunculus samples were frozen, freeze-dried 
and extracted with methanol in a triplicate. A metabolic profiling carried out by means 
of 1H-NMR spectroscopy and multivariate data analysis was applied to the crude 
methanol extracts, as well as their chloroform fractions. NMR spectra were compared 
with the statistical methods PCA (principal component analysis) as well as PLS-DA 
(partial least squares - discriminant analysis) and PLS (partial least squares). 
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Metabolomics proved to be a powerful technique not only to show a significant 
difference between samples from EGS sites and control sites, but it also showed the 
differences between different Ranunculus species and different metabolite profiles 
depending on what season the samples had been collected.  
Another aim was to show if soil properties have an impact on the metabolic range of 
the Ranunculus samples. The results indicate that high levels of iron, nitrate or 
chromium might have an impact on the variation in the metabolite composition of the 
extracts. 
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6. Zusammenfassung 
 
Equine grass sickness (EGS) oder Graskrankheit ist eine Polyneuropathie, die das 
zentrale, periphere und enterale Nervensystem von grasenden Pferden betrifft. EGS 
tritt häufig in Großbritannien auf, es kommt aber auch auf dem europäischen 
Festland vor. Die Krankheit befällt hauptsächlich junge Pferde mit Zugang zu Weiden 
im Frühling. Obwohl EGS seit über 100 Jahren bekannt ist, ist die Ursache bis heute 
ungeklärt. Neuere Studien deuten darauf hin dass Intoxikation mit Clostridium 
butulinum type C involviert sein könnte. Es ist jedoch sehr wahrscheinlich dass EGS 
eine multifaktorielle Krankheitsursache hat.  
Das Ziel dieser Arbeit war herauszufinden ob es einen Zusammenhang zwischen 
phytochemischen Daten von Ranunculus Proben und EGS gibt. Um diese Hypothese 
zu beweisen wurden Ranunculus Proben von 12 Standorten gesammelt auf denen 
EGS Fälle aufgetreten sind und von 9 Standorten auf denen EGS noch nie 
vorgekommen ist. 
Frische Hahnenfüße enthalten Ranunculin, ein Glykosid, aus welchem durch 
enzymatische Umwandlung der toxische Metabolit Protoanemonin gebildet wird. 
Durch die Reizwirkung von Protoanemonin können Läsionen im Gastrointestinaltrakt 
von Pferden entstehen. Das Bakterium Clostridium botulinum kann dadurch 
erleichtert in die Blutbahn gelangen. 
Für die phytochemische Analyse wurden alle Ranunculus Proben tiefgekühlt, 
lyophilisiert und dreimal mit Methanol extrahiert. Sowohl von den Methanol-
Extrakten, also auch von deren Chloroform-Fraktionen wurden 1H-NMR Spektra 
aufgenommen. Die Spektra wurden mittels multivariater Datenanalyse verglichen. 
Die statistischen Methoden PCA (principal component analysis), PLS-DA (partial 
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least squares - discriminant analysis) und PLS (partial least squares) wurden 
verwendet.  
Durch diese Methoden konnten signifikante Unterschiede zwischen Proben von EGS 
Standorten und Kontrollstandorten festgestellt werden. Außerdem war es möglich die 
Unterschiede in der Zusammensetzung unterschiedlicher Ranunculus Spezies zu 
zeigen und jahreszeitliche Schwankungen in der chemischen Zusammensetzung der 
Pflanzenproben nachzuweisen.  
Ein weiteres Ziel war zu ermitteln, ob die Konzentration von bestimmten 
Bodenparametern sich auf die metabolische Zusammensetzung der gesammelten 
Ranunculus Proben auswirken könnten. Die Resultate zeigen, dass erhöhte 
Konzentrationen an Eisen, Nitrat oder Chrom einen Einfluss auf die Pflanzen haben 
könnten. 
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Appendix 
 
1. Sample data 
Sample 
name 
Time of 
freezing Wet weight 
Waters 
content 
Weight of 
material 
packed into 
column 
Weight of 
dry 
extract 
Drug 
extract 
ratio 
GM1/1 15 month 12.123 76.5% 2.784 512.25 5.4 
GM1/2 15 month 4.810 75.8% 1.112 264.75 4.2 
GM1/3 15 month 4.816 77.9% 0.990 274.79 3.6 
GM2/2 11 month 5.843 81.8% 1.054 294.50 3.6 
GM2/3 11 month 5.253 83.4% 0.828 225.24 3.7 
GM2/4 11 month 3.681 86.4% 0.500 144.29 3.5 
GM3/2 10 month 6.648 81.9% 1.204 199.82 6.0 
GM3/3 10 month 2.748 79.0% 0.530 172.44 3.1 
GM3/4 8 month 2.517 73.7% 0.663 178.73 3.7 
GM4/1 8 month 15.436 69.3% 4.780 990.66 4.8 
GM4/2 7 month 3.230 82.8% 0.532 119.58 4.4 
GM4/3 7 month 2.423 80.6% 0.444 115.00 3.9 
GM5/1 7 month 16.293 74.0% 4.216 810.69 5.2 
GM5/2 7 month 2.554 77.5% 0.606 170.74 3.5 
GM5/3 7 month 2.827 80.3% 0.593 145.43 4.1 
GM6/1 6 month 2.532 77.1% 0.554 140.19 4.0 
GM6/2 6 month 2.577 82.9% 0.365 101.87 3.6 
GM6/3 6 month 2.862 81.4% 0.486 117.36 4.1 
GM7/1 2 month 3.057 80.2% 0.418 104.10 4.0 
GM7/2 2 month 4.223 80.2% 0.671 135.77 4.9 
GM7/3 2 month 3.238 80.9% 0.454 131.46 3.5 
GM8/1 1 month 4.224 92.5% 0.379 61.91 6.1 
GM8/2 1 month 4.379 93.0% 0.367 80.04 4.6 
GM8/3 
 
1 month 
 
5.641 
 
93.7% 
 
0.410 
 
62.72 
 
6.5 
 
II 
Sample 
name 
Time of 
freezing Wet weight 
Water 
content 
Weight of 
material 
packed into 
column 
Weight of 
dry 
extract 
Drug 
extract 
ratio 
GM9/1 3 weeks 2.845 83.2% 0.415 89.63 4.6 
GM9/2 3 weeks 4.248 77.6% 0.896 154.85 5.8 
GM9/3 3 weeks 3.564 73.9% 0.873 98.57 8.9 
GM10/1 2 weeks 3.725 85.0% 0.548 138.69 4.0 
GM10/2 2 weeks 4.522 84.8% 0.736 143.45 5.1 
GM10/3 2 weeks 3.666 81.9% 0.654 119.33 5.5 
C1/1 15 month 2.300 58.0% 0.951 284.33 3.3 
C1/4 14 month 2.842 65.8% 0.985 253.87 3.9 
C1/5 11 month 2.883 73.8% 0.756 166.51 4.5 
C7/1 8 month 3.160 75.2% 0.828 233.30 3.5 
C7/2 8 month 2.680 57.8% 1.197 316.81 3.8 
C7/3 8 month 3.318 57.5% 1.389 381.43 3.6 
C8/1 8 month 2.638 26.5% 1.932 533.44 3.6 
C8/2 8 month 2.796 55.8% 1.189 267.18 4.5 
C8/3 8 month 2.871 62.2% 1.038 267.44 3.9 
C9/1 7 month 2.790 76.7% 0.772 212.63 3.6 
C9/2 7 month 2.941 83.5% 0.549 158.45 3.5 
C9/3 7 month 3.843 81.5% 0.797 205.01 3.9 
C10/1 7 month 2.560 78.8% 0.485 143.81 3.4 
C10/2 7 month 2.607 79.6% 0.495 151.77 3.3 
C10/3 7 month 2.570 77.3% 0.543 156.19 3.5 
C11/1 7 month 2.843 69.3% 0.859 186.94 4.6 
C11/2 7 month 2.735 70.0% 0.821 187.85 4.4 
C11/3 7 month 2.804 73.7% 0.734 173.22 4.2 
C12/1 7 month 1.644 53.6% 0.763 204.10 3.7 
C12/2 7 month 1.646 65.9% 0.562 104.84 5.4 
C12/3 
 
 
7 month 
 
 
1.522 
 
 
60.8% 
 
 
0.596 
 
 
130.76 
 
 
4.6 
 
 
III 
Sample 
name 
Time of 
freezing 
Wet 
weight 
Water 
content 
Weight of 
material 
packed into 
column 
Weight of 
dry 
extract 
Drug 
extract 
ratio 
C13/1 7 month 1.878 33.3% 1.249 218.46 5.7 
C13/2 7 month 2.397 59.7% 1.000 255.63 3.9 
C13/3 7 month 2.428 69.0% 0.777 154.23 5.0 
C14/1 7 month 2.191 60.3% 0.839 206.11 4.1 
C14/2 7 month 2.191 73.5% 0.570 150.70 3.8 
C14/3 7 month 3.376 74.4% 0.855 227.45 3.8 
C15/1 7 month 2.582 74.1% 0.677 199.24 3.4 
C15/2 7 month 2.564 77.1% 0.623 160.33 3.9 
C15/3 7 month 2.986 78.1% 0.679 171.99 3.9 
C16/1 7 month 1.886 31.3% 1.231 243.23 5.1 
C16/2 7 month 1.929 44.5% 1.037 181.02 5.7 
C16/3 7 month 2.257 55.9% 0.970 209.43 4.6 
C17/1 6 month 2.361 61.1% 0.934 237.57 3.9 
C17/2 6 month 2.913 75.6% 0.765 224.31 3.4 
C17/3 6 month 2.895 79.5% 0.610 163.32 3.7 
EGS1/1 23 month 3.125 75.9% 0.784 167.17 4.7 
EGS1/2 23 month 3.438 63.2% 1.298 474.76 2.7 
EGS1/3 23 month 3.260 75.8% 0.817 200.05 4.1 
EGS2/1 23 month 1.288 28.6% 0.874 197.29 4.4 
EGS2/2 23 month 1.824 39.5% 1.049 269.57 3.9 
EGS2/3 23 month 1.697 41.0% 0.957 174.50 5.5 
EGS3/1 23 month 2.919 59.0% 1.175 354.27 3.3 
EGS3/2 23 month 3.130 66.6% 1.029 360.37 2.9 
EGS3/3 23 month 2.504 72.3% 0.689 181.85 3.8 
EGS5/1 23 month 3.235 75.1% 0.871 158.02 5.5 
EGS5/2 23 month 3.732 70.9% 1.115 240.86 4.6 
EGS5/3 
 
 
23 month 
 
 
4.924 
 
 
67.9% 
 
 
1.182 
 
 
174.93 
 
 
6.8 
 
 
IV 
Sample 
name 
Time of 
freezing 
Wet 
weight 
Water 
content 
Weight of 
material 
packed into 
column 
Weight of 
dry 
extract 
Drug 
extract 
ratio 
EGS6/1 23 month 2.269 57.3% 0.952 252.66 3.8 
EGS6/2 23 month 2.833 63.5% 1.046 176.12 5.9 
EGS6/3 23 month 3.698 69.1% 1.130 253.54 4.5 
EGS7/1 23 month 2.619 65.5% 0.888 375.46 2.4 
EGS7/2 23 month 3.100 84.7% 0.469 122.08 3.8 
EGS7/3 23 month 3.774 76.5% 0.885 280.92 3.2 
EGS8/1 22 month 3.489 77.4% 0.815 245.82 3.3 
EGS8/2 22 month 3.781 86.8% 0.519 144.99 3.6 
EGS8/3 22 month 2.955 71.8% 0.866 239.60 3.6 
EGS9/1 21 month 2.403 56.3% 1.024 198.54 5.2 
EGS9/2 21 month 1.865 57.5% 0.806 108.27 7.4 
EGS9/3 21 month 2.624 63.7% 0.952 122.94 7.7 
EGS10/1 20 month 3.047 74.1% 0.863 289.06 3.0 
EGS10/2 20 month 4.463 84.3% 0.713 245.48 2.9 
EGS10/3 20 month 4.271 83.0% 0.735 256.81 2.9 
EGS11/1 20 month 2.613 60.3% 1.025 122.63 8.4 
EGS11/2 20 month 3.055 62.2% 1.127 98.73 11.4 
EGS11/3 20 month 3.265 59.4% 1.314 147.68 8.9 
EGS12/1 16 month 4.205 80.5% 0.795 235.75 3.4 
EGS12/2 16 month 3.322 74.5% 0.855 272.75 3.1 
EGS12/3 16 month 6.221 79.5% 1.251 299.84 4.2 
EGS13/1 15 month 4.118 76.7% 0.924 213.91 4.3 
EGS13/2 15 month 3.054 84.4% 0.460 109.57 4.2 
EGS13/3 15 month 4.854 87.6% 0.627 161.54 3.9 
EGS14/1 12 month 3.383 63.3% 1.257 272.18 4.6 
EGS14/2 12 month 3.141 56.0% 1.458 389.72 3.7 
EGS14/3 12 month 2.847 40.1% 1.716 397.40 4.3 
 
       
V 
Sample 
name 
Time of 
freezing 
Wet 
weight 
Water 
content 
Weight of 
material 
packed into 
column 
Weight of 
dry 
extract 
Drug 
extract 
ratio 
EGS15/1 12 month 2.910 49.3% 1.461 379.84 3.8 
EGS15/2 12 month 3.567 58.0% 1.466 393.73 3.7 
EGS15/3 12 month 3.731 64.1% 1.330 379.49 3.5 
EGS16/1 12 month 1.978 63.2% 0.729 183.56 4.0 
EGS16/2 12 month 1.827 59.7% 0.739 158.94 4.6 
EGS16/3 12 month 1.845 53.5% 0.731 172.91 4.2 
EGS17/1 12 month 7.861 87.4% 0.991 243.89 4.1 
EGS17/2 12 month 6.029 84.9% 0.864 177.63 4.9 
EGS17/3 12 month 9.477 92,2% 0.742 171.15 4.3 
EGS18/1 12 month 1.710 25,7% 1.235 385.89 3.2 
EGS18/2 12 month 2.916 53,9% 1.345 403.03 3.3 
EGS18/3 12 month 1.863 48,5% 0.994 254.31 3.9 
EGS19/1 10 month 2.951 78,3% 0.556 114.72 4.8 
EGS19/2 10 month 2.992 79,2% 0.583 151.52 3.8 
EGS19/3 10 month 1.891 71,2% 0.508 147.22 3.5 
 
VI 
2. Soil parameters 
Table 8: Parameters of soil samples collected at control sites (C). 
 
C1 
C7 
C8 C9 C10 
C11 
C12 C13 
C14 
C16 C15 C17 
Nitrate Nitrogen mg/kg 11.28 10.8 24.9 23.2 7.44 9.95 23.4 7.57 16.03 
Ammonium Nitrogen mg/kg 12.76 18 9.64 7.09 13 3.78 4.34 4.71 21.7 
Phosphorus mg/l 38.40 55.60 54.80 33.60 34.20 14.00 14.00 8.00 12.60 
Potassium mg/l 535 224 227 248 410 126 266 114 201 
Magnesium mg/l 318 147 76 126 103 111 104 100 97 
Copper mg/kg 27.40 11.70 12.70 14.30 12.00 26.40 12.60 28.00 13.70 
Zinc mg/kg 98.50 49.50 77.80 53.20 35.60 67.60 55.10 73.10 50.10 
Total iron mg/kg 17688 18976 41395 18883 11435 18810 13617 26103 14409 
Available iron mg/kg 319.7 518.10 140.20 181.50 335.00 248.30 347.1 144.00 178.00 
Lead mg/kg 109.0 43.20 55.90 28.00 25.00 52.80 40.50 67.50 32.10 
Arsenic mg/kg 10.6 9 49.2 9.9 6 11 5 14.3 5.7 
Cadmium mg/kg 0,41 0.24 0.91 0.23 0.18 0.39 0.24 0.75 0.22 
Mercury mg/kg 0.3 0.07 0.02 0.08 0.04 0.07 0.05 0.18 0.04 
Nickel mg/kg 12.2 10.3 18.7 16.9 10 21.5 12.4 38.8 11.1 
Selenium mg/kg 0.44 0,33 0.24 0.37 0.27 0.35 0.33 0.31 0.26 
Fluoride mg/kg 31.3 21.4 17.6 25.2 12.6 11.8 11 13.9 23.1 
Chromium mg/kg 28.3 15.2 39.4 25.7 16.3 24.4 18.7 18 30.6 
Molybdenum mg/kg 1.9 1.3 1 0.6 1 0.9 0.6 1.2 0.9 
Aluminium mg/kg 7884 5699 4437 10738 6350 10599 9524 9443 14037 
VII 
Table 9: Parameters of soil samples collected at Equine Grass Sickness sites (E). 
 
E1 E2 E3 
E5 
E6 E7 E8 E9 
E10 
E11 E12 E13 
E14 
E15 
E17 
E18 E19 
Nitrate Nitrogen mg/kg 44.5 44.9 27.0 37.6 24.0 26.9 62.0 23.3 3.8 0.1 3.9 9.8 7.8 
Ammonium Nitrogen mg/kg 18.1 69.4 23.9 7.99 0.97 1.66 3.02 1.45 11.4 26.2 17.5 5.62 2.28 
Phosphorus mg/l 48.0   46.0 36.8 66.2 46.0 55.8 27.8 32.0 15.0 25.4 72.8 0.0 
Potassium mg/l       127 495 261 431 134 61 38 101 215 0 
Magnesium mg/l       70 203 124 87 191 95 82 35 99 0 
Copper mg/kg 13.3 20.1 6.3 31.2 17.1 13.8 19.1 30.3 26.5 16.5 23.9 29.0 8.6 
Zinc mg/kg 86.1 120.0 42.4 134.0 70.4 76.1 72.0 105.0 76.8 106.0 81.3 241.0 34.2 
Total Fe mg/kg 21309 25176 8602 64672 17474 13800 13574 20331 15823 29703 22319 16489 12930 
Available Fe mg/kg 568.0   325.0 214.0 334.8 426.3 253.9 376.7 496.0 311.0 146.3 171.6 0.00 
Lead mg/kg 43.8 36.2 16.0 49.5 31.30 25.60 50.60 62.00 29.70 65.00 60.10 44.90 21.80 
Arsenic mg/kg 10.8 10.6 4.5 29.5 10.3 6.3 7.5 12.7 5.7 11.3 10.8 21.3 7.7 
Cadmium mg/kg 0.28 0.24 0.12 0.67 0.25 0.16 0.26 0.44 0.54 0.4 0.41 0.53 0.2 
Mercury mg/kg 0.08 0.08 0.07 0.08 0.05 0.03 0.12 0.19 0.07 0.11 0.1 0.03 0.04 
Nickel mg/kg 21 35.1 10.3 32.1 13.1 10 13.8 23.4 15.4 15.1 18 16.2 10.5 
Selenium mg/kg 0.34 0.58 0.27 0.36 0.18 0.17 0.22 0.48 0.68 0.7 0.52 0.27 0.27 
Fluoride mg/kg       86.9 32.7 13.2 18.8 26.5 31.1 30.8 11.8 13.4 12.7 
Chromium mg/kg 37.4 60.2 18 57.5 24.6 23 18.8 41.4 24.4 32.2 19.7 29.8 12 
Molybdenum mg/kg 1 1.8 0.7 0.2 0.6 0.4 0.7 0.5 2.8 1.3 1 1.2 0.4 
Aluminium mg/kg                 6067 13509 9574 4811 5242 
VIII 
3. PLS results (PC 1 vs. PC2) of R. repens methanol extracts 
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XIII 
4. PLS results (PC 1 vs. PC2) of R. repens chloroform extracts 
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